HDAC9 and breast carcinoma: In this experiment, human colon and breast cancer cell lines were used to determine the effects of the demethylation agent, 5-Aza-2'deoxycytidine (5-aza-DC), and the HDAC inhibitor, sodium butyrate (SB), and the two agents combined on radiosensitivity.